Public Awareness and Perceptions of Colorectal Cancer Prevention: a Cross-Sectional Survey

Knudsen, Markus Dines; Hoff, Geir; Tidemann-Andersen, Ida; Bodin, Gry Ekeberg; Øvervold, Sissel; Berstad, Paula

doi:10.1007/s13187-020-01721-5

Cited by 15 publications

(13 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent studies suggest that the general public are interested in receiving personal genomic risk information for breast cancer, 11,12,23 prostate cancer 11 and kidney cancer 24 that provision of this information is unlikely to result in high levels of distress and uncertainty 25 or have a negative impact on cancer worry, anxiety and fear 26 . Awareness of personal risk factors has also been associated with willingness to participate in bowel cancer screening 27 …”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Acceptability of risk‐stratified population screening across cancer types: Qualitative interviews with the Australian public

Dunlop

Rankin

Smit

et al. 2021

Health Expectations

View full text Add to dashboard Cite

Background There is mounting evidence of the benefit of risk‐stratified (risk‐tailored) cancer population screening, when compared to standard approaches. However, shifting towards this approach involves changes to practice that may give rise to implementation challenges. Objectives To explore the public's potential acceptance of risk‐stratified screening across different cancer types, including reducing screening frequency if at low risk and the use of personal risk information, to inform implementation strategies. Method Semi‐structured interviews were conducted with 40 public participants; half had received personal genomic risk information and half had not. Participants were prompted to consider different cancers. Data were analysed thematically as one dataset. Results Themes included the following: (a) a sense of security; (b) tailored screening is common sense; (c) risk and the need to take action; (d) not every cancer is the same; and (e) trust and belief in health messages. Both groups expressed similar views. Participants were broadly supportive of risk‐stratified screening across different cancer types, with strong support for increased screening frequency for high‐risk groups. They were less supportive of reduced screening frequency or no screening for low‐risk groups. Findings suggest the public will be amenable to reducing screening when the test is invasive and uncomfortable; be less opposed to forgo screening if offered the opportunity to screen at some stage; and view visible cancers such as melanoma differently. Conclusions Approaching distinct cancer types differently, tailoring messages for different audiences and understanding reasons for participating in screening may assist with designing future implementation strategies for risk‐stratified cancer screening.

show abstract

Section: Introductionmentioning

confidence: 99%

“… 26 Awareness of personal risk factors has also been associated with willingness to participate in bowel cancer screening. 27 …”

Section: Introductionmentioning

confidence: 99%

Acceptability of risk‐stratified population screening across cancer types: Qualitative interviews with the Australian public

Dunlop

Rankin

Smit

et al. 2021

Health Expectations

View full text Add to dashboard Cite

show abstract

“…19,[31][32][33] By contrast, studies from Turkey, Norway, the United States, and Spain found better awareness levels than this study. 18,[34][35][36] Possible contributing factor to the higher awareness in these studies could be the availability of established national screening programs in these countries, which has been shown to motivate participants to adopt healthier behaviors including those related to CRC. 37,38 To date, there is no national screening program for CRC in Palestine, and this warrants future consideration to reduce CRC-related mortality.…”

Section: Discussionmentioning

confidence: 99%

Awareness of Colorectal Cancer Risk Factors in Palestine: Where Do We Stand?

Elshami

Dwikat

Al‐Slaibi³

et al. 2022

JCO Global Oncology

View full text Add to dashboard Cite

PURPOSE To assess the public awareness level of colorectal cancer (CRC) risk factors in Palestine and identify factors associated with the good awareness level. MATERIALS AND METHODS Adult Palestinians were recruited using convenience sampling from hospitals, primary health care centers, and public locations in 11 governorates. The recognition of 11 CRC risk factors was evaluated using a translated-into-Arabic version of the validated bowel cancer awareness measure. Participants were given one point for each correctly recognized risk factor. The awareness level was determined by the number of CRC risk factors recognized: poor (0-3), fair (4-7), and good awareness (8-11). RESULTS A total of 4,877 participants, of 5,254 approached, completed the questionnaire (response rate = 92.3%). The final analysis included 4,623 questionnaires, 2,700 from the West Bank and Jerusalem (WBJ) and 1,923 from the Gaza Strip. Participants from the WBJ were older, gained higher monthly income, and had more chronic diseases than participants from the Gaza Strip. The most recognized modifiable CRC risk factor was not doing 30 minutes of moderate physical activity five times a week (n = 3,846, 83.2%), whereas the least recognized was having a diet low in fiber (n = 1,985, 42.9%). The most recognized nonmodifiable CRC risk factor was having a bowel disease (n = 3,320, 71.8%), whereas the least recognized was having diabetes (n = 1,581, 34.2%). Only 1,840 participants (39.8%) demonstrated good awareness of CRC risk factors. Participants from the Gaza Strip were more likely than participants from the WBJ to have good awareness (46.5.0% v 35.0%). Female sex, knowing someone with cancer, and completing postsecondary education were all associated with good awareness. CONCLUSION Awareness of CRC risk factors was found to be low in Palestine. There is a substantial need to raise awareness of CRC risk factors through educational campaigns and programs.

show abstract

“…This strategy requires an active interaction between healthcare providers and the population to identify individual risk and to reach a proper balance between health assistance and personal preferences, the potential benefits and disadvantages of the test/program offered, and to obtain a real shared and informed decision. Proper cancer risk awareness significantly improves preventive program adherence [ 4 ].…”

Section: Cancer Prevention Overviewmentioning

confidence: 99%

Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine

Serrano

Patrignani

Stigliano³

et al. 2022

Genes

View full text Add to dashboard Cite

Cancer prevention in the era of precision medicine has to consider integrated therapeutic approaches. Therapeutic cancer prevention should be offered to selected cohorts with increased cancer risk. Undoubtedly, carriers of hereditary cancer syndromes have a well-defined high cancer risk. Lynch Syndrome is one of the most frequent hereditary syndromes; it is mainly associated with colorectal cancer (CRC). Nonsteroidal anti-inflammatory drugs and, in particular, aspirin use, has been associated with reduced CRC risk in several studies, initially with contradictory results; however, longer follow-up confirmed a reduced CRC incidence and mortality. The CAPP2 study recruited 861 Lynch syndrome participants randomly assigned to 600 mg of aspirin versus placebo. Like sporadic CRCs, a significant CRC risk reduction was seen after an extended follow-up, with a median treatment time that was relatively short (2 years). The ongoing CAPP3 will address whether lower doses are equally effective. Based on pharmacology and clinical data on sporadic CRCs, the preventive effect should also be obtained with low-dose aspirin. The leading international guidelines suggest discussing with Lynch syndrome carriers the possibility of using low-dose aspirin for CRC prevention. We aim systematically promote this intervention with all Lynch syndrome carriers.

show abstract

Public Awareness and Perceptions of Colorectal Cancer Prevention: a Cross-Sectional Survey

Cited by 15 publications

References 24 publications

Acceptability of risk‐stratified population screening across cancer types: Qualitative interviews with the Australian public

Acceptability of risk‐stratified population screening across cancer types: Qualitative interviews with the Australian public

Awareness of Colorectal Cancer Risk Factors in Palestine: Where Do We Stand?

Aspirin Colorectal Cancer Prevention in Lynch Syndrome: Recommendations in the Era of Precision Medicine

Contact Info

Product

Resources

About